Neoadjuvant Chemotherapy in the Medicare Cohort with Advanced Ovarian Cancer()

OBJECTIVE: The value of neoadjuvant chemotherapy (NAC) for the treatment of advanced ovarian cancer has yet to be determined. While NAC may facilitate and simplify complete cytoreduction and reduce the risk of surgery, the delay of surgery related to NAC needs to be balanced against any potential be...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Thrall, Melissa M., Gray, Heidi J., Symons, Rebecca Gaston, Weiss, Noel S., Flum, David R., Goff, Barbara A.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3217095/
https://ncbi.nlm.nih.gov/pubmed/21945309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.08.030
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki